Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 55.83B | 56.30B | 54.06B | 52.55B | 48.88B | 45.91B |
Gross Profit | 6.66B | 6.61B | 6.97B | 6.41B | 6.57B | 6.47B |
EBITDA | 3.65B | 3.60B | 4.32B | 3.84B | 3.92B | 3.45B |
Net Income | 1.53B | 1.49B | 2.01B | 1.71B | 1.84B | 1.49B |
Balance Sheet | ||||||
Total Assets | 26.01B | 30.48B | 30.99B | 29.53B | 27.49B | 26.01B |
Cash, Cash Equivalents and Short-Term Investments | 5.78B | 7.19B | 8.02B | 6.69B | 5.61B | 5.78B |
Total Debt | 6.08B | 4.41B | 5.20B | 6.54B | 5.61B | 6.08B |
Total Liabilities | 13.76B | 13.62B | 14.92B | 14.89B | 13.84B | 13.76B |
Stockholders Equity | 12.25B | 16.87B | 16.07B | 14.65B | 13.66B | 12.25B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 936.13M | 2.97B | 758.42M | 1.15B | 1.12B |
Operating Cash Flow | 0.00 | 1.72B | 3.96B | 2.00B | 2.57B | 2.28B |
Investing Cash Flow | 0.00 | -993.75M | -715.48M | -1.12B | -1.61B | -691.61M |
Financing Cash Flow | 0.00 | -1.56B | -1.91B | 198.58M | -1.14B | -2.02M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥18.78B | 12.45 | 3.99% | 4.15% | -25.67% | ||
68 Neutral | ¥8.77B | 20.11 | ― | 10.60% | 15.70% | ||
66 Neutral | ¥9.96B | 13.53 | 1.46% | 20.50% | 62.39% | ||
66 Neutral | ¥8.84B | 12.23 | 2.66% | 22.23% | 57.78% | ||
63 Neutral | ¥8.68B | 15.69 | 1.46% | 21.97% | -20.94% | ||
52 Neutral | $7.45B | 0.27 | -61.87% | 2.30% | 16.62% | 1.04% | |
49 Neutral | ¥21.13B | 159.73 | 3.00% | 29.51% | -175.29% |